A carregar...
“Holidays” for osteoporosis drugs: A case-based approach
• A “drug holiday” can be considered for patients at low fracture risk; • It is optimal after completion of five years of alendronate and three years of zoledronic acid or risedronate use; • The “drug holiday” strategy should not be implemented for denosumab, estrogen, SERMs or teriparatide....
Na minha lista:
| Publicado no: | Case Rep Womens Health |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6580330/ https://ncbi.nlm.nih.gov/pubmed/31431887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.crwh.2019.e00127 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|